A multi-center, three-year study to evaluate optical coherence tomography as an endpoint in patients with multiple sclerosis
PPD, Parmaceutical Product Development S.L.
Pathology and candidate patients
Dr. Luís Martí Bonmatí
Hospital Quirónsalud Valencia.
August 30, 2012
If you are interested in this clinical trial because you believe that you or a family member of yours can benefit from this new treatment.
You can request a consultation with the image diagnosis team by sending an email to the address: email@example.com